Results 41 to 50 of about 159,964 (350)

Helicobacter pylori and Biliary Tract Cancers: A Meta-Analysis

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, 2020
Background. Helicobacter pylori is detected in various extragastric diseases, including biliary tract cancers. Besides, gallbladder cancers, extracholangiocarcinomas, and intracholangiocarcinomas are highly lethal cancers with limited survival due to ...
Soumia Cherif   +4 more
doaj   +1 more source

Single-cell atlas of diverse immune populations in the advanced biliary tract cancer microenvironment

open access: yesnpj Precision Oncology, 2022
Immunotherapies have been explored in treating solid tumors, albeit with disparate clinical effects in distinct cancer types. Systematic interrogation of immune cells in the tumor microenvironment (TME) is vital to the prediction of immunotherapy ...
Xuebing Shi   +19 more
doaj   +1 more source

The footprint of gut microbiota in gallbladder cancer: a mechanistic review

open access: yesFrontiers in Cellular and Infection Microbiology
Gallbladder cancer (GBC) is the most common malignant tumor of the biliary system with the worst prognosis. Even after radical surgery, the majority of patients with GBC have difficulty achieving a clinical cure. The risk of tumor recurrence remains more
Shujie Liu   +24 more
doaj   +1 more source

A single‐arm, multicenter, open‐label phase 2 trial of surufatinib in patients with unresectable or metastatic biliary tract cancer

open access: yesCancer, 2021
Several clinical studies of vascular endothelial growth factor/vascular endothelial growth factor receptor (VEGF/VEGFR) therapy as a second‐line treatment for biliary tract cancer (BTC) have shown modest efficacy. In this study, surufatinib was evaluated
Jianming Xu   +11 more
semanticscholar   +1 more source

Tumor mutational burden as a determinant of metastatic dissemination patterns

open access: yesMolecular Oncology, EarlyView.
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal   +4 more
wiley   +1 more source

Low expression of RACK1 is associated with metastasis and worse prognosis in cholangiocarcinoma

open access: yesHeliyon
Background: Cholangiocarcinoma is a poorly prognostic malignant tumor, and the metastatic stage of cancer is not an early stage when diagnosed. Lymph node metastasis is common in the early stage.
Zhihui Gao   +9 more
doaj   +1 more source

Changing Landscape of Systemic Therapy in Biliary Tract Cancer

open access: yesCancers, 2022
Simple Summary Cancers from the bile ducts and gall bladder are lethal. Cure by surgery is not possible in most of these tumors as they are often identified in later stages. Unlike other cancers, they have few chemotherapy treatment options.
E. Woods, Dat Le, B. Jakka, A. Manne
semanticscholar   +1 more source

Clinical Conditions Associated With a High Antinuclear Antibody Titer in Individuals Without Autoimmune Disease

open access: yesArthritis Care &Research, EarlyView.
Objective Antinuclear antibodies (ANAs) are present at high titers in 2% of the general population, but their clinical significance in individuals without an autoimmune (AI) disease is not known. We tested the hypothesis that the presence of a high ANA titer in non‐AI conditions is associated with disease.
Matthew Chung   +7 more
wiley   +1 more source

Differential Item Functioning on the Patient Health Questionnaire‐8 by Disease Subtype, Language, Sex, and Age among People with Systemic Sclerosis: A Scleroderma Patient‐centered Intervention Network Cohort Study

open access: yesArthritis Care &Research, Accepted Article.
Objective Somatic items used in depression assessments can potentially overlap with symptoms related to physical illness, including systemic sclerosis (SSc). No studies have looked at whether somatic depression items may be influenced by diffuse versus limited SSc disease subtypes, which are associated with varying degrees of symptom presentation.
Sophie Hu   +109 more
wiley   +1 more source

MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers.

open access: yesPLoS ONE, 2015
It is difficult to detect pancreatic cancer or biliary-tract cancer at an early stage using current diagnostic technology. Utilizing microRNA (miRNA) markers that are stably present in peripheral blood, we aimed to identify pancreatic and biliary-tract ...
Motohiro Kojima   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy